Profile data is unavailable for this security.
About the company
Read Gene SA is a Poland-based company primarily engaged in the biotechnology sector. The Company is focused on research and technologies which aim is to detect, prevent and treat malignant tumors. The company's main segments are chemoprevention, clinical trials and genetic testing which are complementary to each other. Chemoprevention involves the use of natural or synthetic substances to inhibit, reverse or delay the process of cancer and in order to achieve that, the Company distributes supplements and food with products with a controlled content of micronutrients and vitamins. The Company provides clinical trials and offers them to corporate clients, mainly from the medical, pharmaceutical, chemical and biotechnology industries. The Company is also offering genetic testing services, including early lung cancer detection test, breast cancer test, colorectal cancer test or prostate cancer risk test.
- Revenue in PLN (TTM)15.19m
- Net income in PLN-887.46k
- Incorporated2005
- Employees11.00
- LocationRead Gene SAGrzepnica, ul. Alabastrowa 8SZCZECIN 72-003PolandPOL
- Phone+48 914334256
- Fax+48 918524433
- Websitehttps://read-gene.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stem Cells Spin SA | 115.74k | -510.92k | 18.19m | 1.00 | -- | 2.78 | 13.94 | 157.15 | -0.0124 | -0.0124 | 0.0028 | 0.1581 | 0.0103 | 0.008 | 3.43 | 115,740.00 | -4.52 | -1.02 | -4.57 | -1.05 | 95.91 | 93.18 | -441.44 | -50.72 | 1.03 | -133.66 | 0.0262 | -- | -87.06 | -37.78 | -237.07 | -- | -- | -- |
| Medicofarma Biotech SA | 281.45k | -3.06m | 33.99m | 24.00 | -- | 7.14 | -- | 120.76 | -0.0450 | -0.0450 | 0.0041 | 0.07 | 0.0199 | 66.64 | 0.7469 | 11,727.08 | -21.55 | -14.96 | -31.48 | -18.59 | 38.80 | 36.02 | -1,085.51 | -64.02 | 0.821 | -11.71 | 0.00 | -- | 63.14 | -17.39 | 33.11 | -- | -- | -- |
| GENOMED SA | 27.49m | 3.27m | 41.22m | 53.00 | 12.60 | 3.31 | 10.23 | 1.50 | 2.48 | 2.48 | 20.81 | 9.42 | 2.21 | 5.17 | 12.68 | 509,166.10 | 26.31 | 7.51 | 28.79 | 8.81 | 65.24 | 62.33 | 11.90 | 3.84 | 7.51 | -- | 0.00 | -- | 2.34 | 3.18 | 19.32 | 1.98 | 15.97 | -- |
| Sds Optic SA | 7.44m | -483.71k | 48.51m | 41.00 | -- | 49.40 | 220.25 | 6.52 | -0.0815 | -0.0815 | 1.25 | 0.1559 | 0.5497 | 5.12 | 125.84 | 181,486.60 | -4.01 | -32.89 | -4.24 | -41.35 | 98.19 | 49.49 | -7.29 | -136.62 | 2.50 | 0.6278 | 0.00 | -- | 40.53 | 301.05 | -45.06 | -- | 57.27 | -- |
| Sygnis SA | 7.73m | -6.34m | 57.60m | 12.00 | -- | 1.79 | -- | 7.45 | -0.2499 | -0.2499 | 0.3309 | 1.17 | 0.1166 | -0.1689 | 6.14 | 218,427.70 | -9.03 | -8.61 | -15.00 | -12.10 | 108.49 | 59.85 | -77.44 | -39.14 | 0.6697 | -0.0066 | 0.13 | -- | -52.29 | 26.88 | -47.44 | -- | -9.50 | -- |
| Read Gene SA | 15.19m | -887.46k | 66.26m | 11.00 | -- | 24.73 | -- | 4.36 | -0.0536 | -0.0536 | 1.17 | 0.2273 | 1.08 | 39.77 | 6.30 | -- | -6.32 | -2.40 | -6.88 | -2.74 | 92.63 | 90.21 | -5.84 | -4.30 | 6.31 | -0.696 | 0.00 | -- | 30.38 | 26.38 | 17.49 | -- | -- | -- |
| Genomtec SA | 15.00k | -11.01m | 75.17m | -- | -- | 7.26 | -- | 5,011.50 | -0.7485 | -0.7485 | 0.001 | 0.6869 | 0.0009 | -- | 0.0143 | -- | -65.47 | -89.96 | -82.11 | -113.38 | -54,120.00 | -4,379.72 | -73,393.34 | -17,225.07 | 2.82 | -39.82 | 0.1409 | -- | 0.00 | -63.42 | -24.35 | -- | -34.54 | -- |
| Urteste SA | 0.00 | -5.47m | 77.83m | 34.00 | -- | 3.32 | -- | -- | -3.88 | -3.88 | 0.00 | 15.35 | 0.00 | -- | -- | -- | -15.56 | -29.65 | -18.99 | -31.35 | -- | -45,933.33 | -- | -623,333.30 | -- | -- | 0.0128 | -- | -- | -- | 35.00 | -- | 197.79 | -- |
| Hyenergy SA | 3.29m | 169.85k | 77.91m | 27.00 | -- | 3.95 | 318.90 | 23.69 | -0.0936 | -0.0936 | 0.1654 | 0.5878 | 0.1821 | 0.1259 | 0.7741 | -- | 0.9403 | 2.39 | 1.28 | 3.35 | 99.70 | 77.46 | 5.16 | 3.11 | 1.30 | 1.17 | 0.00 | -- | 192.83 | 19.47 | 100.30 | -- | -45.79 | -- |
| Nanogroup SA | -6.90k | -6.93m | 87.65m | -- | -- | 7.51 | -- | -- | -0.1844 | -0.1844 | -0.0002 | 0.3553 | -0.0003 | 2.64 | -- | -- | -30.59 | -29.50 | -51.55 | -33.80 | -- | 66.72 | -- | -2,258.26 | 0.9785 | -464.18 | 0.00 | -- | 3.96 | -64.09 | 34.50 | -- | 3.07 | -- |
| Poltreg SA | 0.00 | -24.56m | 127.31m | 33.00 | -- | 2.57 | -- | -- | -5.27 | -5.27 | 0.00 | 10.61 | 0.00 | 16.45 | -- | 0.00 | -25.87 | -9.02 | -29.62 | -10.18 | -- | -659.36 | -- | -854.23 | 2.65 | -- | 0.1365 | -- | -74.98 | -6.89 | -38.06 | -- | 83.47 | -- |
| Mabion SA | 14.81m | -59.30m | 132.53m | 204.00 | -- | 1.89 | -- | 8.95 | -3.67 | -3.67 | 0.9164 | 4.33 | 0.0988 | 8.10 | 27.25 | 72,602.94 | -39.56 | 0.5366 | -54.81 | 1.06 | -178.55 | 58.34 | -400.37 | 0.9643 | 0.2276 | -- | 0.04 | -- | -54.50 | -- | -115.35 | -- | 6.00 | -- |
| Molecure SA | 5.11m | -24.42m | 151.85m | 71.00 | -- | 1.70 | -- | 29.70 | -1.20 | -1.20 | 0.2493 | 4.34 | 0.0553 | -- | 7.01 | 50,119.41 | -26.42 | -3.15 | -27.53 | -3.30 | 51.48 | 93.34 | -477.67 | -15.45 | -- | -- | 0.0588 | -- | -40.47 | 278.20 | -10.27 | -- | 12.49 | -- |
